Preferences
Related Series
Related Segments
Patient Intake Management 2024
Where Are Vendors Delivering Value?
Consumerism and patient-centric tools are an increasing focus in healthcare—previous KLAS research validated that patients’ top priority for patient engagement technology is the ability to schedule appointments and check in online. Patient intake management solutions offer such capabilities, among others, and can help improve patient engagement and satisfaction. These solutions experienced exponential growth during the COVID-19 pandemic, and they continue to be important as healthcare organizations work toward increased efficiency and cost savings. While all measured vendors have room to improve functionality (e.g., two-way patient texting, patient satisfaction surveys), this report validates the breadth and depth of patient intake management solutions, identifies the outcomes these solutions drive, and examines the respective merits of third-party and EHR solutions.
If you don't have a login, getting started is easy.
Key Findings:
- Phreesia Has Largest Market Share & Broadest, Deepest Adoption; Best in KLAS Winner Yosi Health Highlighted for High-Quality Support; R1 Software Improves Patient Satisfaction
- Epic & Kyruus Health (Epion) Score Highly & Have Strong Integration with Their Respective EHR Solutions
- Office Staff Efficiency & Reduced Manual Work Are Most Common Outcomes Reported by Customers
- Enhanced Functionality & Customization Are Top Reasons Customers Use Third-Party Patient Intake Management Solutions
Writer
Natalie Hopkins
Designer
Bronson Allgood
Project Manager
Andrew Wright
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.